Publications

publication banner

2022

REPRODUCTIVE OPHTHALMOLOGY: The Intersection of Inherited Eye Diseases and Reproductive Technologies.   |   J.G. Park; C.L. Xu; A. Boyd; L. Aghajanova; V.B. Mahajan; E.H. Wood   |   Details

2021

Intravitreal Fluocinolone Acetonide (Retisert) Implantation Using a Keratome Blade.   |   M.Veerappan Pasricha; N.F. Callaway; V.B. Mahajan   |   Details
An intravitreal implant injection method for sustained drug delivery into mouse eyes.   |   Y.Joo Sun; C.H. Lin; M.R. Wu; S.Hyeon Lee; J. Yang; C.R. Kunchur; E.M. Mujica; B. Chiang; Y.Soo Jung; S. Wang; V.B. Mahajan   |   Details
Telegenetics for inherited retinal diseases in the COVID-19 environment.   |   A. Al-Moujahed; A. Kumar; T. Chemudupati; S.H. Tsang; V.B. Mahajan   |   Details
Genetics of Uveitis.   |   E.T. Cunningham; F. Pichi; V.B. Mahajan; J.T. Rosenbaum; M. Zierhut   |   Details
Peptidomimetics Therapeutics for Retinal Disease.   |   D.E. Parsons; S.Hyeon Lee; Y.Joo Sun; G. Velez; A.G. Bassuk; M. Smith; V.B. Mahajan   |   Details
Structure-based phylogeny identifies Avoralstat as a TMPRSS2 inhibitor that prevents SARS-CoV-2 infection in mice.   |   Y.Joo Sun; G. Velez; D.E. Parsons; K. Li; M.E. Ortiz; S. Sharma; P.B. McCray; A.G. Bassuk; V.B. Mahajan   |   Details
Liquid biopsy proteomics of uveal melanoma reveals biomarkers associated with metastatic risk.   |   G. Velez; H.V. Nguyen; T. Chemudupati; C.A. Ludwig; M. Toral; S. Reddy; P. Mruthyunjaya; V.B. Mahajan   |   Details
The Present and Future of Mitochondrial-Based Therapeutics for Eye Disease.   |   M.H. Ji; A. Kreymerman; K. Belle; B.K. Ghiam; S.P. Muscat; V.B. Mahajan; G.M. Enns; M. Mercola; E.H. Wood   |   Details
Molecular Characterization of a Rare Case of Bilateral Vitreoretinal T Cell Lymphoma through Vitreous Liquid Biopsy.   |   A.K. Cani; M.A. Toral; D.A. Balikov; B.L. Betz; K. Hu; C.J. Liu; M.V. Prifti; A.M. Chinnaiyan; S.A. Tomlins; V.B. Mahajan; R.C. Rao   |   Details

2020

Proteomic analysis of intermediate uveitis suggests myeloid cell recruitment and implicates IL-23 as a therapeutic target.   |   Y.J. Sepah; G. Velez; P.H. Tang; J. Yang; T. Chemudupati; A.S. Li; Q.D. Nguyen; A.G. Bassuk; V.B. Mahajan   |   Details
Phenotypic variance in Calpain-5 retinal degeneration.   |   P.H. Tang; T. Chemudupati; K.J. Wert; J.C. Folk; M. Mahajan; S.H. Tsang; A.G. Bassuk; V.B. Mahajan   |   Details
Modulation of Post-Traumatic Immune Response Using the IL-1 Receptor Antagonist Anakinra for Improved Visual Outcomes.   |   L.P. Evans; A.W. Woll; S. Wu; B.P. Todd; N. Hehr; A. Hedberg-Buenz; M.G. Anderson; E.A. Newell; P.J. Ferguson; V.B. Mahajan; M.M. Harper; A.G. Bassuk   |   Details
Optical Gap Biomarker in Cone-Dominant Retinal Dystrophy.   |   J.Kyun Oh; J. Ryu; J.Ronaldo Li de Carvalho; S.R. Levi; W. Lee; E. Tsamis; V.C. Greenstein; V.B. Mahajan; R. Allikmets; S.H. Tsang   |   Details
Reply.   |     |   Details
Sex Differences in the Repair of Retinal Detachments in the United States.   |   N.F. Callaway; D. Vail; A. Al-Moujahed; C. Ludwig; M.H. Ji; V.B. Mahajan; S. Pershing; D.M. Moshfeghi   |   Details
Quantitative Autofluorescence Following Gene Therapy With Voretigene Neparvovec.   |   S.R. Levi; J.Kyun Oh; J.Ronaldo Li de Carvalho; V.B. Mahajan; S.H. Tsang; J.R. Sparrow   |   Details
Whole-Exome Sequencing of Patients with Posterior Segment Uveitis.   |   A.S. Li; G. Velez; B. Darbro; M.A. Toral; J. Yang; S.H. Tsang; P.J. Ferguson; J.C. Folk; A.G. Bassuk; V.B. Mahajan   |   Details
Intravitreal methotrexate and fluocinolone acetonide implantation for Vogt-Koyanagi-Harada uveitis.   |   J.G. Park; N.F. Callaway; C.A. Ludwig; V.B. Mahajan   |   Details
Sex Does Not Influence Visual Outcomes After Blast-Mediated Traumatic Brain Injury but IL-1 Pathway Mutations Confer Partial Rescue.   |   L.P. Evans; N. Boehme; S. Wu; E.L. Burghardt; A. Akurathi; B.P. Todd; E.A. Newell; P.J. Ferguson; V.B. Mahajan; L.M. Dutca; M.M. Harper; A.G. Bassuk   |   Details

Pages